HCT116 (colorectal cancer) was included as an out-of-lineage control, and JQ1, an established potent inhibitor of BET family proteins BRD2, 3, 4, was included as an inhibitor of bromodomain proteins with a distinct selectivity profile. This evidence concerns the gene BRD2 and colorectal cancer.